醫生論癌症：認知及治療

如何减低患癌的风险？
癌症有哪些治疗方法？
手术后癌症会复发吗？
癌症是绝症吗？
可以“饿死”癌细胞吗？

这些是许多人心中的疑惑。

在现今社会，每三个人当中，便有一人在其一生当中会罹患癌症。癌症显然已经成为常见疾病，唯有多加认识，才能远离癌症威胁，一旦确诊也可以勇敢面对，接受正确的疗法，对抗癌症。

毫无根据的治疗法，只会让病情加剧。本书旨在让你了解正确的癌症知识，解开你心中的疑惑。让黄醒荣医生以简单易懂的方式，带你走出癌症治疗的误区。

How can we reduce our risk of getting cancer?
What kind of cancer treatments are there?
Will cancer relapse even after surgery?
Is cancer a death sentence?
Can you “starve” cancer cells to death?

These are the questions haunting the minds of many.

In this developed society, every one in three people will develop cancer within his or her lifetime. Cancer is now a common disease. Having a better understanding about cancer helps one keep a distance from it. However, in the case of a diagnosis, face it bravely and obtain the right treatment to fight cancer.

Baseless treatment methods will only worsen one’s condition. This book aims to impart correct knowledge on cancer and answers to questions many have about this much-misunderstood disease. Let Dr. Wong Seng Weng enlighten you with his straightforward and easy-to-understand explanations.

作者介紹

黄醒荣 Wong Seng Weng

新加坡国立大学医学和外科医学学士、英国皇家内科医生学会会员、新加坡医学院院士（肿瘤内科）
新加坡医疗集团癌症中心医务总监兼肿瘤内科医生

黄醒荣医生目前在新加坡医疗集团癌症中心百丽宫及伊丽莎白山诺维娜专科中心担任医务总监兼肿瘤内科顾问医生。他亦是新加坡医疗集团的执行董事和医疗委员会主席。
在此之前，黄医生以林文庆和陈锡九奖学金，在新加坡国立大学考获医学学士学位，并以杰出的学术成就，被列入院长嘉许名单。他在内科完成了培训实习，并成为英国皇家医生学会会员。之后，他获得新加坡卫生部专科认证，同时获认可为新加坡医学会会员，并考获新加坡医学院院士。黄医生接着在新加坡国立大学医院从事临床医疗工作，并受聘为新加坡国立大学肿瘤内科临床导师。除此之外，黄医生热忱投身于科研，积极参与了二十多例临床实验，探索新的癌症治疗方法。黄医生曾担任莱佛士医院肿瘤内科顾问医生及资深伙伴，负责所有内科肿瘤科服务。
除了癌症中心，黄医生现在也是伊丽莎白山医院及伊丽莎白山诺维娜医院的肿瘤内科客座顾问医生。
在研究方面，他受委为新加坡科技研究局属下生物工程与纳米科技研究院的附属临床科学家。
黄医生是肿瘤学报刊《MIMS Oncology》的编辑顾问委员会成员。
黄医生是美国临床肿瘤学会、欧洲临床肿瘤学会和新加坡肿瘤学会的活跃会员。他经常在越南、菲律宾、泰国、缅甸、中国、印度、孟加拉、马来西亚及印尼举行的国际癌症研讨会上发表演讲。
黄医生擅长于成人癌症的诊断与治疗，尤其专长于乳腺癌、肺癌和消化道癌症。
 
MBBS (S’pore), MRCP (UK), FAMS (Medical Oncology)
Medical Director, Medical Oncologist, The Cancer Centre

Dr Wong Seng Weng is currently the Medical Director and Consultant Medical Oncologist of The Cancer Centre (Singapore Medical Group) at the Paragon and Mount Elizabeth Novena Specialists’ Centres. He is an executive member of the Board of Directors and chairman of the Medical Board of the Singapore Medical Group.
Dr Wong obtained his basic medical degree from the National University of Singapore (NUS) under the Lim Boon Keng and Tan Siak Kew Scholarships and graduated on the Dean’s List for outstanding academic achievement. He completed his post-graduate training in Internal Medicine and obtained his Membership of the Royal College of Physicians of the United Kingdom (MRCP UK). Thereafter, he achieved Specialist Accreditation with the Ministry of Health Singapore and was admitted as Fellow of the Academy of Medicine of Singapore (FAMS) and College of Physicians of Singapore. Dr Wong continued his practice in the National University Hospital and was appointed clinical tutor of the clinical faculty of the National University of Singapore. Apart from pursuing his clinical practice, Dr Wong was keenly involved as an investigator in over twenty clinical trials exploring novel methods of cancer treatment. He previously held the posts of Consultant Medical Oncologist and Senior Partner of the Raffles Cancer Centre in charge of all oncology services at the Raffles Hospital.
Apart from his practice at The Cancer Centre, Dr Wong is currently a visiting consultant medical oncologist of Mount Elizabeth Hospital and Mount Elizabeth Novena Hospital.
In the area of research, he holds the appointment of Adjunct Clinician Scientist of the Institute of Bioengineering and Nanotechnology (IBN) in the Agency for Science, Technology and Research (A*STAR).
Dr Wong is part of the editorial advisory board of the oncology newspaper MIMS Oncology.
Dr Wong is an active member of the American Society of Clinical Oncology (ASCO) as well as the European Society for Medical Oncology (ESMO) and Singapore Society of Oncology. He lectured widely at international cancer conferences in Vietnam, the Philippines, Thailand, Myanmar, China, India, Bangladesh, Malaysia and Indonesia.
Dr Wong specializes in the diagnosis and treatment of adult cancers with special interest in breast cancers, lung cancers and gastrointestinal cancers.